论文部分内容阅读
目的:观察康艾注射液在晚期肿瘤患者化疗中的辅助作用。方法:按照年龄、性别、疾病种类、KPS评分、疾病分期等配对设计,治疗组化疗加康艾注射液40ml,静脉滴注d1-10天;对照组化疗加参麦注射液。治疗前后分别观察生活质量、临床症状、体重、免疫功能、血象等变化。结果:治疗组患者生活质量、临床症状改善率、体重较对照组提高,免疫功能抑制、骨髓抑制等不良反应较对照组低。结论:康艾注射液联合化疗可改善化疗患者的生活质量,减轻化疗相关的免疫抑制、骨髓抑制等不良反应。
Objective: To observe the auxiliary effect of Kangai Injection in the chemotherapy of advanced cancer patients. Methods: According to the age, sex, type of disease, KPS score, disease staging and other matching design, the treatment group chemotherapy plus Kang Ai injection 40ml, intravenous infusion d1-10 days; control group plus Shenmai injection. Before and after treatment were observed quality of life, clinical symptoms, weight, immune function, blood and other changes. Results: The quality of life, the improvement of clinical symptoms, the improvement of body symptom, the suppression of immune function and the suppression of bone marrow suppression in the treatment group were lower than those in the control group. Conclusions: Kangai injection combined with chemotherapy can improve the quality of life in patients with chemotherapy, reduce chemotherapy-related immunosuppression, bone marrow suppression and other adverse reactions.